Fugen Cullu Cokugras

Fugen Cullu Cokugras

Auto-generated profile, based on publicly available information

Fugen Cullu Cokugras

European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Pediatrics
Verified
Journal Article
Closed access
PDF file
MUMerve Usta
Merve Usta
TETülay Erkan
Tülay Erkan
FCFugen Cullu Cokugras
Fugen Cullu Cokugras
NUNafiye Urganci
Nafiye Urganci
ZOZerrin Onal
Zerrin Onal
TKTufan Kutlu
Tufan Kutlu
OBJECTIVE: Caustic substance ingestion in childhood is a public health issue in developing countries, and several management protocols have been proposed to prevent the resulting esophageal strictures. The role of corticosteroids in preventing corrosive-induced strictures is controversial. Our aim was to study the influence of high doses of corticosteroids in preventing esophageal strictures. METHODS: Eighty-three children with a mean age of 4.10 ± 2.63 years and with grade IIb esophageal burns (an esophagogastroscopy was performed within 24–48 hours of injury) due to corrosive substance ingestion were enrolled in our study between 2005 and 2008. Forty-two children (study group) received methylprednisolone (1 g/1.73 m2 per day for 3 days), ranitidine, ceftriaxone, and total parenteral nutrition. Forty-one children (control group) were administered the same regimen excluding methylprednisolone. Stricture development was compared between groups based on endoscopic and radiologic findings. RESULTS: During the endoscopic examination, stricture development was observed in 4 patients (10.8%) in the study group and in 12 patients (30%) in the control group. The difference was statistically significant (P = .038). The stricture development rate in the upper gastrointestinal system with barium meal was 14.3% and 45.0% in the study and control groups, respectively. The difference was statistically significant (P = .004). The duration of total parenteral nutrition was shorter in the study group compared with the control group (P = .001). High doses of methylprednisolone were well tolerated in the study group without any side effects. CONCLUSIONS: High doses of methylprednisolone used for the management of grade IIb esophageal burns may reduce stricture development.

23 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Valentina FabianoValentina Fabiano
Valentina Fabiano
FLAVIA INDRIOFLAVIA INDRIO
FLAVIA INDRIO
Elvira VerduciElvira Verduci
Elvira Verduci
Valeria CalcaterraValeria Calcaterra
Valeria Calcaterra
Tudor Lucian PopTudor Lucian Pop
Tudor Lucian Pop
OGOlivier Goulet
Olivier Goulet
Intestinal colonization of the neonate is highly dependent on the term of pregnancy, the mode of delivery, the type of feeding [breast feeding or formula feeding]. Postnatal immune maturation is dependent on the intestinal microbiome implementation and composition and type of feeding is a key issue in the human gut development, the diversity of microbiome, and the intestinal function. It is well established that exclusive breastfeeding for 6 months or more has several benefits with respect to formula feeding. The composition of the new generation of infant formulas aims in mimicking HM by reproducing its beneficial effects on intestinal microbiome and on the gut associated immune system (GAIS). Several approaches have been developed currently for designing new infant formulas by the addition of bioactive ingredients such as human milk oligosaccharides (HMOs), probiotics, prebiotics [fructo-oligosaccharides (FOSs) and galacto-oligosaccharides (GOSs)], or by obtaining the so-called post-biotics also known as milk fermentation products. The aim of this article is to guide the practitioner in the understanding of these different types of Microbiota Influencing Formulas by listing and summarizing the main concepts and characteristics of these different models of enriched IFs with bioactive ingredients.

3 April 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ÖBÖmer Faruk Beşer
Ömer Faruk Beşer
FCFugen Cullu Cokugras
Fugen Cullu Cokugras
GDGuzide Dogan
Guzide Dogan
ÖAÖzlem Akgün
Özlem Akgün
MEMurat Elevli
Murat Elevli
Yvan VandenplasYvan Vandenplas
Yvan Vandenplas

3 May 2019 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MPMassimo Pettoello-Mantovani
Massimo Pettoello-Mantovani
FÇFügen Çullu Çokuğraş
Fügen Çullu Çokuğraş
MVMEHMET VURAL
MEHMET VURAL
JMJulije Mestrovic
Julije Mestrovic
LNLuigi Nigri
Luigi Nigri
LNLeyla S. Namazova-Baranova
Leyla S. Namazova-Baranova
Consumers’ conviction of the benefits of probiotics is influenced by their existing beliefs and by the information they receive from healthcare professionals. The attitude of healthcare professionals towards commercially available probiotics will, therefore, determine how trustworthy and beneficial these products are perceived by consumers. Furthermore, due to European Union legislation, companies are prohibited from displaying information on product packaging; therefore, consumers are dependent primarily on healthcare professionals for correct information and guidance on the use of these products. The aim of this pilot study was to explore the understanding and use of probiotics in clinical practice by professionals who are involved in child healthcare in different European countries and to assess how much they value the scientific evidence behind these products. The study was performed using a cross-sectional, descriptive, 30-question online questionnaire circulated among healthcare professionals belonging to three professional categories that are typically involved in childhood probiotic prescription: paediatricians, dieticians and general practitioners. The questionnaire was developed using web-based standard guidelines, and the questions were modelled on those used in previously published probiotics studies. Overall, 27,287 healthcare professionals belonging to three major European scientific societies were contacted by the organizations participating in the study. In total, 1360 valid questionnaires were recorded, and the results were statistically analysed. The results emphasize the importance for healthcare professionals to be properly educated and updated on probiotics. An improved knowledge about probiotics led to increased prescriptive confidence. To disseminate accurate information on probiotics, healthcare professionals look for appropriate and scientifically validated educational platforms to acquire information, explore concerns and barriers and look for positive approaches towards recommending probiotics.

3 August 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
ASAyse Ayzit Kilinc Sakalli
Ayse Ayzit Kilinc Sakalli
ÖBÖmer Faruk Beşer
Ömer Faruk Beşer
PKPelin Ugur Karaboga
Pelin Ugur Karaboga
FCFugen Cullu Cokugras
Fugen Cullu Cokugras
HCHaluk Cokugras
Haluk Cokugras

3 September 2019 in European Journal of Rheumatology
Verified
Journal Article
Open access
YSYasin Sahin
Yasin Sahin
SSSezgin Sahin
Sezgin Sahin
AAAmra Adrovic Adrovic
Amra Adrovic Adrovic
TKTufan Kutlu
Tufan Kutlu
FÇFügen Çullu Çokuğras
Fügen Çullu Çokuğras
OKOzgur Kasapcopur
Ozgur Kasapcopur
Objective: The aim of the present study was to investigate the frequency of celiac disease (CD) in patients with juvenile systemic lupus erythematosus (JSLE) and the potential association of JSLE and CD. Methods: This was a cross-sectional study performed from October 2015 to October 2017. A total of 50 patients with JSLE were included in the study. The levels of total IgA and tissue transglutaminase (tTG) IgA antibody were measured in all patients. Subjects with increased tTG were further evaluated for anti-endomysial antibodies (EMAs). Gastroduodenoscopy and intestinal biopsy were performed in those with increased EMA levels to confirm the diagnosis of CD. Results: The study included 44 (88.0%) female and 6 (12.0%) male patients. Of the 50 patients, 30 (60.0%) received corticosteroids, and only 4 (8.0%) received no therapy at the time of the study. Only 3 (6.0%) patients were positive for tTG IgA. Patients with positive tTG IgA were then tested for EMA IgA antibodies, and none of them had a positive result. Conclusion: We did not find CD in children with systemic lupus erythematosus. Studies with more patients with JSLE are needed to conclude a more precise result. Cite this article as: Şahin Y, Şahin S, Adrovic A, Kutlu Tufan, Çullu Çokuğraş F, Barut K, et al. Serological screening for celiac disease in children with systemic lupus erythematosus. Eur J Rheumatol 2019; 6(3): 142-5.